Form 8-K - Current report:
SEC Accession No. 0001023024-06-000023
Filing Date
2006-07-24
Accepted
2006-07-24 11:54:31
Documents
4
Period of Report
2006-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOSANTE FORM 8K JULY 24 2006 biosante8k7-21.htm 8-K 39251
2 FORM OF WARRANT formofwarrant.htm EX-10.2 100722
3 BIOSANTE PRESS RELEASE 7-24-06 pressrelease7-24.htm EX-99.1 16920
4 BIOSANTE LOGO pressrelease1.jpg GRAPHIC 7689
  Complete submission text file 0001023024-06-000023.txt   169316
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 06975889
SIC: 2836 Biological Products, (No Diagnostic Substances)